Zenara Pharma receives DCGI approval to manufacture, sell Favipiravir tablets

Zenara Pharma, a fully owned subsidiary of Biophore India Pharmaceuticals, announced that it has received approval from the Drugs Controller General of India (DCGI), to manufacture and sell Favipiravir tablets as a treatment option for patients with mild to moderate symptoms of COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/33uIlJm
via IFTTT